Lv3
318 积分 2024-01-04 加入
Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial
22小时前
待确认
Final Results of the Chrysalis Trial: A First-in-Human Phase 1/2 Dose-Escalation, Dose-Expansion Study of Gilteritinib (ASP2215) in Patients with Relapsed/Refractory Acute Myeloid Leukemia (R/R AML)
3天前
已完结
A Meta‐Analysis on Gilteritinib Using Real‐World and Randomized Trial Data in Patients With FLT3‐Mutated Refractory/Relapsed Acute Myeloid Leukemia
3天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
8天前
已完结
Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer
8天前
已完结
ERK signalling: a master regulator of cell behaviour, life and fate
1个月前
已完结
GSK3 inhibitors: development and therapeutic potential
2个月前
已完结
Belt and braces for BCR–ABL
2个月前
已完结
Abemaciclib impairs glioblastoma sphere formation by targeting the GSK3β-mediated transcriptional regulation of CD44 and TCF7L2
2个月前
已完结
Discovery of Atirmociclib (PF-07220060): A Potent and Selective CDK4 Inhibitor
2个月前
已完结
皖公网安备34019202002308
